Literature DB >> 31859579

Adolescent and Young Adult Oral Maxillofacial Tumors: A Single-Institution Case Series and Literature Review.

Anil P George1, Michael R Markiewicz2,3, Steven Garzon4, Daniel K Choi1.   

Abstract

Adolescent and young adult (AYA) oral maxillofacial tumors are rare and account for ∼12% of all AYA cancers. Due to the low incidence of these malignancies, diagnostic considerations, therapeutic approaches, and factors affecting prognosis have been difficult to characterize. Given the anatomic structures located within the head and neck, patients are at risk for treatment-related morbidity that may adversely impact their quality of life. We present a single-institution case series of AYA patients with oral maxillofacial tumors treated at the University of Illinois at Chicago. A multidisciplinary treatment approach, including collaboration with the Oral Maxillofacial Surgery, Dentistry, and the Ear, Nose, and Throat teams along with the utilization of Children's Oncology Group treatment protocols, can serve as a model to address the challenges in the management of these complex cases.

Entities:  

Keywords:  chondroblastic osteosarcoma; maxillofacial tumors; mesenchymal chondrosarcoma; squamous cell carcinoma

Mesh:

Year:  2019        PMID: 31859579      PMCID: PMC7476397          DOI: 10.1089/jayao.2019.0111

Source DB:  PubMed          Journal:  J Adolesc Young Adult Oncol        ISSN: 2156-5333            Impact factor:   2.223


  37 in total

1.  Clinicopathological and immunohistochemical analysis of twenty-five head and neck osteosarcomas.

Authors:  Ademar Takahama Junior; Fábio de Abreu Alves; Clóvis Antonio Lopes Pinto; André Lopes Carvalho; Luiz Paulo Kowalski; Márcio Ajudarte Lopes
Journal:  Oral Oncol       Date:  2003-07       Impact factor: 5.337

2.  Expanded Access Through Cancer Trials Support Unit to Children's Oncology Group Sarcoma Trial AEWS1031 for Adolescents and Young Adults.

Authors:  Leo Mascarenhas; Mason C Bond; Nita L Seibel
Journal:  J Adolesc Young Adult Oncol       Date:  2011-03       Impact factor: 2.223

3.  Pediatric head and neck bone sarcomas: An analysis of 204 cases.

Authors:  Jacob S Brady; Sei Y Chung; Emily Marchiano; Jean Anderson Eloy; Soly Baredes; Richard Chan Woo Park
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2017-06-15       Impact factor: 1.675

4.  Free osseous and soft tissue surgical margins as prognostic factors in mandibular osteosarcoma.

Authors:  Martin Granados-Garcia; Kuauhyama Luna-Ortiz; Herbert A Castillo-Oliva; Veronica Villavicencio-Valencia; Angel Herrera-Gómez; Adalberto Mosqueda-Taylor; Jose L Aguilar-Ponce; Adela Poitevin-Chacón
Journal:  Oral Oncol       Date:  2005-10-24       Impact factor: 5.337

5.  Mesenchymal chondrosarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study on 57 patients.

Authors:  Yusuke Tsuda; Koichi Ogura; Michiyuki Hakozaki; Kazutaka Kikuta; Keisuke Ae; Hiroyuki Tsuchiya; Shintaro Iwata; Takafumi Ueda; Hirotaka Kawano; Akira Kawai
Journal:  J Surg Oncol       Date:  2017-05       Impact factor: 3.454

6.  Bone sarcomas of the head and neck in children: the St Jude Children's Research Hospital experience.

Authors:  N C Daw; H H Mahmoud; W H Meyer; J J Jenkins; S C Kaste; C A Poquette; L E Kun; C B Pratt; B N Rao
Journal:  Cancer       Date:  2000-05-01       Impact factor: 6.860

Review 7.  Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients.

Authors:  L E Smeele; P J Kostense; I van der Waal; G B Snow
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

8.  Craniofacial osteosarcoma Experience of the cooperative German-Austrian-Swiss osteosarcoma study group.

Authors:  Sven Jasnau; Ulrich Meyer; Jenny Potratz; Gernot Jundt; Matthias Kevric; Ulrich K Joos; Heribert Jürgens; Stefan S Bielack
Journal:  Oral Oncol       Date:  2007-04-27       Impact factor: 5.337

9.  Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups.

Authors:  Tobias M Dantonello; Christoph Int-Veen; Ivo Leuschner; Andreas Schuck; Rhoikos Furtwaengler; Alexander Claviez; Dominik T Schneider; Thomas Klingebiel; Stefan S Bielack; Ewa Koscielniak
Journal:  Cancer       Date:  2008-06       Impact factor: 6.860

10.  Mesenchymal chondrosarcoma. An analysis of patients treated at a single institution.

Authors:  Marilena Cesari; Franco Bertoni; Patrizia Bacchini; Mario Mercuri; Emanuela Palmerini; Stefano Ferrari
Journal:  Tumori       Date:  2007 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.